Federal Reserve Economic Data

FRED Economic Data, St. Louis FED

Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Net Sales, Receipts, and Operating Revenues (QFR101385USNO)

Observation:

Q3 2024: 176,890 (+ more)   Updated: Dec 10, 2024 9:07 AM CST
Q3 2024:  176,890  
Q2 2024:  165,397  
Q1 2024:  154,202  
Q4 2023:  159,954  
Q3 2023:  153,323  
View All

Units:

Millions of Dollars,
Not Seasonally Adjusted

Frequency:

Quarterly

NOTES

Source: U.S. Census Bureau  

Release: Quarterly Financial Report  

Units:  Millions of Dollars, Not Seasonally Adjusted

Frequency:  Quarterly

Notes:

Further information related to the Quarterly Financial Report survey can be found at https://www.census.gov/econ/qfr/about.html
Methodology details can be found at https://www.census.gov/econ/qfr/documents/QFR_Methodology.pdf

Suggested Citation:

U.S. Census Bureau, Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Net Sales, Receipts, and Operating Revenues [QFR101385USNO], retrieved from FRED, Federal Reserve Bank of St. Louis; https://fred.stlouisfed.org/series/QFR101385USNO, .

RELEASE TABLES

Quarterly Financial Report

RELATED DATA AND CONTENT

Data Suggestions Based On Your Search

Content Suggestions

Related Categories

Financial Activity Measures Financial Indicators Money, Banking, & Finance

Releases

More Series from Quarterly Financial Report

Tags

Medicines Pharmaceuticals Quarterly Financial Report Operating Receipts Revenue Chemicals Finance Nondurable Goods Corporate Net Sales Goods Manufacturing Industry Quarterly Census Nation Public Domain: Citation Requested Not Seasonally Adjusted United States of America

Need Help?

Questions or Comments
FRED Help

Subscribe to the FRED newsletter

Follow us

Back to Top